Clinical Trials Logo

Postoperative Hemorrhage clinical trials

View clinical trials related to Postoperative Hemorrhage.

Filter by:

NCT ID: NCT05174988 Completed - Clinical trials for Patient Satisfaction

Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles

Start date: January 31, 2022
Phase: N/A
Study type: Interventional

The investigators propose prospectively evaluating if adding separate sutures to the angles of the vaginal cuff before running barbed suture reduces the incidence of patient's perception of bleeding after surgery.

NCT ID: NCT05093504 Terminated - Clinical trials for Blood Loss, Surgical

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

STAR-D
Start date: December 27, 2021
Phase: N/A
Study type: Interventional

Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious Bleeding in Patients Undergoing Urgent Cardiothoracic Surgery

NCT ID: NCT05077124 Recruiting - Clinical trials for Blood Loss, Surgical

Safe and Timely Antithrombotic Removal (STAR) Registry

Start date: September 30, 2021
Phase:
Study type: Observational

This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents.

NCT ID: NCT05047133 Recruiting - Clinical trials for Postoperative Blood Loss

Effect of Early Administration of TXA in Adult Hip Fractures

Start date: September 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This is a prospective clinical study designed to assess blood loss in intracapsular and extracapsular hip fractures undergoing operative fixation at a Level II trauma center. It is well established in the orthopedic literature that tranexamic acid (TXA) decreases blood loss and need for postoperative blood transfusion in hip fracture patients as well as total joint arthroplasty patients. A typical dosing pattern, and the dosing pattern employed at our institution, is 1 gram IV infused prior to incision followed by 1 gram IV infused at the time of wound closure.

NCT ID: NCT04976530 Completed - Clinical trials for Blood Loss, Surgical

Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)

STAR-T
Start date: August 31, 2021
Phase: N/A
Study type: Interventional

Prospective, multi-center, double-blind, randomized pivotal trial to evaluate the safety and effectiveness of the DrugSorb-ATR system for intraoperative removal of ticagrelor in patients undergoing urgent cardiothoracic (CT) surgery with cardiopulmonary bypass (CPB).

NCT ID: NCT04933253 Withdrawn - Clinical trials for Blood Loss, Surgical

Mediastinal Temperature and Post-operative Bleeding

Start date: October 2022
Phase: N/A
Study type: Interventional

This study will investigate how chest temperature relates to blood loss and blood clotting. Researchers will use infra-red thermometers to measure the temperature of the chest at the end of surgery see if this relates to the amount of blood collected from the surgical drains. In addition, researchers will test if warm irrigation of the chest increases the temperature of the chest and if this impacts blood loss.

NCT ID: NCT04855877 Recruiting - Clinical trials for Anterior Cruciate Ligament Rupture

Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis

Start date: July 6, 2021
Phase: Phase 4
Study type: Interventional

To find superiority relationship between oral and intravenous administration of tranexamic acid on peroperative and postoperative blood loss, haemarthrosis prevalence and improvement functional prognosis in anterior cruciate ligament arthroscopy.

NCT ID: NCT04754230 Completed - Chronic Sinusitis Clinical Trials

Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery

Start date: June 17, 2021
Phase: Phase 4
Study type: Interventional

The purpose of the research is to assess the effectiveness of a dose of intravenous tranexamic acid (TXA) given intraoperatively to reduce postoperative bleeding after endoscopic sinus or nasal surgery (e.g. septoplasty, endoscopic sinus surgery, turbinate surgery). This medication has been shown to decrease blood loss during this type of surgery, but the implications for bleeding following surgery are unclear. Any impact on postoperative bleeding will be assessed over the first 7 days following surgery leading up to the first scheduled postoperative clinic visit. Patients will keep a standardized daily diary of their bleeding experience by indicating on a 0-10 visual analog scale (VAS) their impression of their bleeding. The primary outcome is the patient-reported visual analog scale (VAS) bleeding score on each day after surgery. The secondary outcomes include the the frequency with which the otolaryngology resident service is requested to evaluate patients in the recovery unit for postoperative bleeding concerns and the frequency of interventions such as application of hemostatic materials, packing, cautery, and/or return to the operating room.

NCT ID: NCT04748081 Completed - Clinical trials for Surgery--Complications

The Major Bleeding Risk Following Hepatectomy

Start date: January 1, 2000
Phase:
Study type: Observational

This study examined long-term incidence rates of major bleeding associated with hepatectomy. The investigators used data from Taiwan's National Health Insurance Research Database. Patients who underwent hepatectomy between 2000 and 2012 were identified by International Classification of Diseases, Ninth Revision, Clinical Modification codes. Variables including gender, age, comorbidities, and prescribed medications were matched between cases and controls. A total of 1,053 patients with hepatectomy and 4,212 matched non-hepatectomy subjects were included in this study.

NCT ID: NCT04725305 Recruiting - Postoperative Pain Clinical Trials

BiZact Tonsillectomy in the Pediatric Population

Start date: June 6, 2021
Phase: N/A
Study type: Interventional

This study has been designed to evaluate how effective the Bizact tonsillectomy device is in reducing operating time and complications that occur after surgery. This device operates in a different way than the standard device that is used for most tonsillectomies. In 2019, a study was conducted in 186 children and adults using this device in tonsillectomies. Results showed lower blood loss and shortened time in surgery. However, the rate for bleeding as a complication after surgery was the same as other procedures that are used in tonsillectomy